Accelerate Diagnostics's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, Accelerate Diagnostics's (NASDAQ:AXDX) reported sales totaled $2.96 million. Despite a 37.79% increase in earnings, the company posted a loss of $14.19 million.
Benzinga ·